New anti-hepatitis C drug BMS-790052 does well in Phase IIa study
Coffee consumption reduces side-effects in people on hepatitis C treatment
Boceprevir response and resistance differs according to HCV genotype 1 subtype
Maraviroc improves liver fibrosis in HIV/hepatitis C co-infected patients
US approval for hepatitis C drug telaprevir
European approval recommended for hepatitis C drug boceprevir
New hepatitis C drugs pose many questions
We’re getting there: towards a comprehensive hepatitis C cure
Telaprevir works well for people with HIV/HCV co-infection
